Team:LCG-UNAM-Mexico/Notebook/2008-July
From 2008.igem.org
(4 intermediate revisions not shown) | |||
Line 126: | Line 126: | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
- | <td class="bodyText"><div align="justify"><p><strong>MODELING:</strong><br> | + | <td class="bodyText"><div align="justify"><p><strong><u>MODELING:</u></strong><br> |
We read chapter 2 of Predictive Microbiology by T.A. McMeekin et al., 1993. It taught us the standard stages of a modeling process, the purpose of mathematical models.<br> | We read chapter 2 of Predictive Microbiology by T.A. McMeekin et al., 1993. It taught us the standard stages of a modeling process, the purpose of mathematical models.<br> | ||
The suggested stages of the modeling process are:<br> | The suggested stages of the modeling process are:<br> | ||
Line 133: | Line 133: | ||
- Mathematical description<br> | - Mathematical description<br> | ||
- Validation and maintenance (Including Function Fitting, Model Validation and Model comparisons)</p> | - Validation and maintenance (Including Function Fitting, Model Validation and Model comparisons)</p> | ||
- | <p>Remarkably this chapter also mentioned the changes of the conductivity of the medium depending on the cellular metabolism, therefore pointing out the importance of having a cellular population which isn’t growing; this to prevent the noise and minimize the conductance change due to bacterial metabolism. </p></td> | + | <p>Remarkably this chapter also mentioned the changes of the conductivity of the medium depending on the cellular metabolism, therefore pointing out the importance of having a cellular population which isn’t growing; this to prevent the noise and minimize the conductance change due to bacterial metabolism. </p> |
+ | <p><strong><u>WET LAB:</u></strong><br></p> | ||
+ | <p><strong>Extraction</strong></p> | ||
+ | <p>Plasmid DNA extraction finished</p> | ||
+ | <p><strong>Bioparts & Transformation</strong></p> | ||
+ | <p>Bioparts (BBa_C0051 and BBa_I729006) transformation in DH5alfa cells using the lab technique.</p> | ||
+ | </td> | ||
</tr> | </tr> | ||
Line 142: | Line 148: | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
- | <td class="bodyText"><div align="justify"><p><strong>MODELING:</strong><br> | + | <td class="bodyText"><div align="justify"><p><strong><u>MODELING:</u></strong><br> |
System to be analyzed, taken from by Iwig et al. (2006):</p> | System to be analyzed, taken from by Iwig et al. (2006):</p> | ||
<p align="center"<img src="https://static.igem.org/mediawiki/igem.org/d/db/Iwig_2006.jpg" alt="Iwig 2006" /></p> | <p align="center"<img src="https://static.igem.org/mediawiki/igem.org/d/db/Iwig_2006.jpg" alt="Iwig 2006" /></p> | ||
Line 151: | Line 157: | ||
<p> | <p> | ||
We also defined the variables and equations for our first approach and built our stoichiometric matrix. This can be found in the modeling section. </p> | We also defined the variables and equations for our first approach and built our stoichiometric matrix. This can be found in the modeling section. </p> | ||
+ | <p><strong><u>WET LAB</u>:</strong><br></p> | ||
+ | <p><strong>Bioparts</strong></p> | ||
+ | <p>Transformation of bioparts (BBa_C0051 and BBa_I729006) in TOP10 cells using the iGEM protocol.(No one cell grew in the DH5alfa transformation from day 3)</p> | ||
+ | <p><strong>Plasmids</strong></p> | ||
+ | <p>Plasmid digestions using the following "recipes":</p> | ||
+ | <table border="1" cellspacing="0" cellpadding="0" width="500"> | ||
+ | <tr> | ||
+ | <td width="50%"><p><strong>pBBMCS5</strong></p></td> | ||
+ | <td width="50%"><p><strong>PRK415</strong></p></td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td width="50%"><p>H2O 3.0 μl</p></td> | ||
+ | <td width="50%"><p>H2O 3.0 μl </p></td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td width="50%"><p>Buffer 2 (10X) 3.0 μl</p></td> | ||
+ | <td width="50%"><p>Buffer 2 (10X) 3.0 μl </p></td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td width="50%"><p>BSA(albmin 100X) 3.0 μl</p></td> | ||
+ | <td width="50%"><p>BSA(albumin 100X) 3.0 μl </p></td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td width="50%"><p>XbaI (5units/μl) 1.5 μl</p></td> | ||
+ | <td width="50%"><p>BamH (5units/μl) 1.5 μl </p></td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td width="50%"><p>HindIII (5units/μl) 1.5 μl </p></td> | ||
+ | <td width="50%"><p>EcoR1 (5units/μl) 1.5 μl </p></td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td width="50%"><p>DNA(plasmids) 18 μl</p></td> | ||
+ | <td width="50%"><p>DNA(plasmids) 18 μl </p></td> | ||
+ | </tr> | ||
+ | </table> | ||
<p><br> | <p><br> | ||
</p></div></td> | </p></div></td> | ||
Line 158: | Line 199: | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
- | <td class="bodyText"><div align="justify"><p><strong>MODELING: </strong><br> | + | <td class="bodyText"><div align="justify"><p><strong><u>MODELING:</u> </strong><br> |
We defined our preliminary model’s assumptions and our equations with their respective stoichiometric matrix. The current assumptions and equations can be found in the Modeling section. </p> | We defined our preliminary model’s assumptions and our equations with their respective stoichiometric matrix. The current assumptions and equations can be found in the Modeling section. </p> | ||
<p>NOTES: <br> | <p>NOTES: <br> | ||
- (d/dt)x=Ʃ(entering flows) - Ʃ(exiting flows)<br> | - (d/dt)x=Ʃ(entering flows) - Ʃ(exiting flows)<br> | ||
- Law of mass action: The flow is equal to the reaction constant times the product of the mass of the reactants. </p> | - Law of mass action: The flow is equal to the reaction constant times the product of the mass of the reactants. </p> | ||
- | <p>TO-DO LIST: <br> | + | <p><u><b>TO-DO LIST: </b></u><br> |
-Start doing simulations with Gepasi, Copasi or Matlab. <br> | -Start doing simulations with Gepasi, Copasi or Matlab. <br> | ||
-Investigate the underlying dynamic of each equation (Law of Mass Action, Hill, Michaelis-Menten, etc.)<br> | -Investigate the underlying dynamic of each equation (Law of Mass Action, Hill, Michaelis-Menten, etc.)<br> | ||
- | -Read the articles on our webpage, especially Adam Arkin’s and the one regarding lambda phage. </p></div></td> | + | -Read the articles on our webpage, especially Adam Arkin’s and the one regarding lambda phage. </p> |
+ | <p><strong><u>WET LAB:</u></strong><br></p> | ||
+ | <p><strong>Gel</strong></p> | ||
+ | <p>We run a Gel to observe the digested plasmids. </p> | ||
+ | <p><img src="https://static.igem.org/mediawiki/2008/f/fe/Gel_04Jul08.png" alt="Gel_04Jul08" width="400" /></p> | ||
+ | <p>We transformed cells with the bioparts by electroporation and we didn't obtain results with TOP10, it seems that the registry parts didn't work with it)</p> | ||
+ | |||
+ | </div></td> | ||
</tr> | </tr> | ||
Line 173: | Line 221: | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
- | <td class="bodyText"><div align="justify"><p><strong>MODELING:</strong></p> | + | <td class="bodyText"><div align="justify"><p><strong><u>MODELING:</u></strong></p> |
<p>MISSING REACTION:<br> | <p>MISSING REACTION:<br> | ||
We forgot to take into account one reaction, cI* degradation (cI* -» 0). Now it has been added to the model. </p> | We forgot to take into account one reaction, cI* degradation (cI* -» 0). Now it has been added to the model. </p> | ||
Line 184: | Line 232: | ||
<p>MODEL:<br> | <p>MODEL:<br> | ||
The first simulation in Matlab was generated. It worked! Everyone should test it and correct or suggest anything necessary.</p> | The first simulation in Matlab was generated. It worked! Everyone should test it and correct or suggest anything necessary.</p> | ||
- | <p>TO-DO LIST:<br> | + | <p><u><b>TO-DO LIST:</u></b><br> |
Defining parameters is our topmost priority (reaction rates, kinetic constants and concentrations). </p></div></td> | Defining parameters is our topmost priority (reaction rates, kinetic constants and concentrations). </p></div></td> | ||
</tr><tr> | </tr><tr> | ||
Line 190: | Line 238: | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
- | <td class="bodyText"><div align="justify"><p>Today we discussed the following with Miguel:</p> | + | <td class="bodyText"><div align="justify"><p><b><u>GROUP MEETING:</b></u><br>Today we discussed the following with Miguel:</p> |
<p><strong>BIOPARTS:</strong><br> | <p><strong>BIOPARTS:</strong><br> | ||
There was information in regards to the transformation of the bioparts. Chiba’s team explained to us that their biopart’s DNA was not in the registry however it was mistakenly set as available. However they assured us that they have the functional bioparts, so we will have to request some DNA directly to the team.</p> | There was information in regards to the transformation of the bioparts. Chiba’s team explained to us that their biopart’s DNA was not in the registry however it was mistakenly set as available. However they assured us that they have the functional bioparts, so we will have to request some DNA directly to the team.</p> | ||
Line 199: | Line 247: | ||
<p><strong>CONTROLS:</strong><br> | <p><strong>CONTROLS:</strong><br> | ||
Now that the experimental work has inevitably been delayed, that time can be invested in defining controls, both positive and negative for the experiment. </p><br> | Now that the experimental work has inevitably been delayed, that time can be invested in defining controls, both positive and negative for the experiment. </p><br> | ||
- | <p><strong>MODELING:</strong><br> | + | <p><strong><u>MODELING:</u></strong><br> |
Defining parameters:<br> | Defining parameters:<br> | ||
Obtaining the kinetic parameters experimentally is impossible right now; we first need the working bioparts. Right now we could get an average half-life of other proteins, which share characteristics with our desired protein (for example, average half-life of membrane proteins to define RcnA’s half-life) and trust that they won’t differ much. Once the experimental work resumes we could compare our parameters with those obtained experimentally. </p> | Obtaining the kinetic parameters experimentally is impossible right now; we first need the working bioparts. Right now we could get an average half-life of other proteins, which share characteristics with our desired protein (for example, average half-life of membrane proteins to define RcnA’s half-life) and trust that they won’t differ much. Once the experimental work resumes we could compare our parameters with those obtained experimentally. </p> | ||
Line 209: | Line 257: | ||
<li>Null is a special variable of the program to define the degradation of a protein, the model was corrected to use this variable. </li> | <li>Null is a special variable of the program to define the degradation of a protein, the model was corrected to use this variable. </li> | ||
</ol> | </ol> | ||
- | <p>TO-DO LIST:<br> | + | <p><u><b>TO-DO LIST:</u></b><br> |
Parameters: We are going to focus on this. </p> | Parameters: We are going to focus on this. </p> | ||
+ | |||
</div></td> | </div></td> | ||
</tr> | </tr> | ||
Line 217: | Line 266: | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
- | <td class="bodyText"><div align="justify"><p><strong>MODELING:</strong></p> | + | <td class="bodyText"><div align="justify"><p><strong><u>MODELING:</u></strong></p> |
<p>Parameters to be defined:<br> | <p>Parameters to be defined:<br> | ||
Half-lives, Promoter efficiency, Dissociation rates and Initial concentrations</p> | Half-lives, Promoter efficiency, Dissociation rates and Initial concentrations</p> | ||
Line 251: | Line 300: | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
- | <td class="bodyText"><div align="justify"><p><strong>MODELING:</strong></p> | + | <td class="bodyText"><div align="justify"><p><strong><u>MODELING:</u></strong></p> |
<p><strong>Michaelis-Menten Kinetics</strong><br> | <p><strong>Michaelis-Menten Kinetics</strong><br> | ||
We read Lehninger Principles of Biochemistry (Many Enzymes Catalyze Reactions with Two or More Substrates, pp.207) to better understand Michaelis-Menten Kinetics. Mariana summarized and condensed the information in a document for everyone else to read. </p></div></td> | We read Lehninger Principles of Biochemistry (Many Enzymes Catalyze Reactions with Two or More Substrates, pp.207) to better understand Michaelis-Menten Kinetics. Mariana summarized and condensed the information in a document for everyone else to read. </p></div></td> | ||
</tr> | </tr> | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
<tr> | <tr> | ||
<td colspan="6"> | <td colspan="6"> | ||
<p align="center"><a href="https://2008.igem.org/Team:LCG-UNAM-Mexico/Notebook/2008-June_2" onMouseOver="hiLite ('Back','a2','Back')" onMouseOut="hiLite('Back','a1','')"> <img name="Back" src="https://static.igem.org/mediawiki/igem.org/5/57/BOTON_BACK1.jpg" border=0 width="200" height="40"/></a> | <p align="center"><a href="https://2008.igem.org/Team:LCG-UNAM-Mexico/Notebook/2008-June_2" onMouseOver="hiLite ('Back','a2','Back')" onMouseOut="hiLite('Back','a1','')"> <img name="Back" src="https://static.igem.org/mediawiki/igem.org/5/57/BOTON_BACK1.jpg" border=0 width="200" height="40"/></a> | ||
- | <a href="https://2008.igem.org/Team:LCG-UNAM-Mexico/Notebook/2008- | + | <a href="https://2008.igem.org/Team:LCG-UNAM-Mexico/Notebook/2008-July_02" onMouseOver="hiLite ('Next','b2','Next')" onMouseOut="hiLite('Next','b1','')"> <img name="Next" src="https://static.igem.org/mediawiki/igem.org/c/c8/BOTON_Next1.jpg" border=0 width="200" height="40"/></a></p> |
</td> | </td> | ||
</tr> | </tr> |
Latest revision as of 03:27, 29 October 2008
LCG-UNAM-Mexico | |||||||||||||||||||||||||||||||||||||||||||||||||||
iGEM 2008 TEAM | |||||||||||||||||||||||||||||||||||||||||||||||||||
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||